Rimantadine was approved by the FDA to treat influenza A
In 1994, Rimantadine, derived from amantadine, was approved by the Food and Drug Administration (FDA) to treat influenza…
Amgen acquired Boulder-based Synergen facility
In 1994, Amgen announced it had acquired Boulder-based Synergen for a $239.6-million or $9.25 per share. Synergen was…
Walter Reed Army Medical Center main building was rededicated and named the Heaton Pavilion
In 1994, Walter Reed Army Medical Center main building was rededicated and named the Heaton Pavilion. The Pavillion…
The Stowers Institute for Medical Research was founded
In 1994, the Stowers Institute for Medical Research was founded by Jim and Virginia Stowers with a $500…
Washington University – St Louis researchers developed a blood test to detect a thyroid cancer gene mutation
In 1994, researcher Helen Donis-Keller and colleagues at Washington University – St. Louis announced they had for the…
Infectious molecular clone of a human T-cell leukemia virus was developed at Washington University – St Louis
In 1994, Washington University – St. Louis reseacher Lee Ratern, MD and colleagues announced they had developed an…
Biotechnology Council of New Jersey was founded
In 1994, The Biotechnology Council of New Jersey (BCNJ) was founded. Today, BioNJ is the life sciences trade…
National Center for Genome Resources was founded
In 1994, National Center for Genome Resources (NCGR) founded with support from Senator Pete Domenici as an independent…
The Medical Research Foundation became an affiliate committee of the OHSU Foundation
In 1994, the Medical Research Foundation (MRF) became an affiliate committee of the Oregon Health & Science University…
Biotechnology | Diagnostics | Disease | FDA | Neurology | Ophthalmogy
Omeros Corp was founded
In 1994, Omeros Corp. was founded in Seattle as a biopharmaceutical company committed to discovering, developing and commercializing…
Biotechnology | Disease | FDA | Medicine
Genentech drug Pulmozyme (dornase alfa) was approved by the FDA
On Dec. 30, 1993, the Genentech drug Pulmozyme (dornase alfa) was approved by the U.S. Food and Drug…
Biotechnology | FDA | Medicine | Therapeutics
FDA approved Risperidone for use as atypical antipsychotic medication
On Dec. 29, 1993, the U.S. Food and Drug Administration (FDA) approved indications for oral risperidone (tablets, oral…
Colon cancer gene was identified
On Dec. 7, 1993, Dana-Farber scientists identified the gene that causes an inherited form of colon cancer, which…
Genentech drug Nutropin was approved
On Nov. 17, 1993, Genentech drug Nutropin was approved by the U.S. Food and Drug Administration (FDA) for…
Bovine somatotropin (BST) was approved by the U.S. Food and Drug Administration
On Nov. 5, 1993, Bovine somatotropin (BST) was approved by the U.S. Food and Drug Administration with the…
Dr. Judes Poirier discovered that apolipoprotein E is a genetic risk factor for Alzheimer’s disease
On Sept. 18, 1993, Dr. Judes Poirier discovered that apolipoprotein E was a genetic risk factor for Alzheimer’s…
Francisco Mojica characterized CRISPR
On Aug. 9, 1993, Francisco Mojica published “Transcription at different salinities of Haloferax mediterranei sequences adjacent to partially…
Biotechnology | Disease | FDA | Therapeutics
FDA approved Betaseron, the first of several biotech products that have had a major impact on multiple sclerosis treatment
On Jul. 23, 1993, the U.S. Food and Drug Administration (FDA) approved Bayer’s Betaseron, the first of several…
Chiron’s Betaseron was approved as the first treatment for multiple sclerosis in 20 years
On Jul. 23, 1993, Chiron and Berlex Laboratories announced that the U.S. Food and Drug Administration (FDA) had…
The Biotechnology Industry Organization was created by the merger of IBA, ABC, and ABTA
On Jul. 1, 1993, The Biotechnology Industry Organization (BIO) was created through the merger of the Industrial Biotechnology…
Organization of Regulatory and Clinical Associates was founded
On Jun. 15, 1983, the Organization of Regulatory and Clinical Associates (ORCA) was founded in Seattle to provide…
The NIH Revitalization Act of 1993 was signed
On Jun. 10, 1993, the U.S. Congress signed the National Institutes of Health Revitalization Act, P.L. 103-43. The…
ZymoGenetics began a $25 million year-long renovation of the The Seattle City Light Steam Plant building
On May 13, 1993, ZymoGenetics began a $25 million year-long renovation of the The Seattle City Light Steam…
CDC reponded to E. coli Outbreak from Hamburgers in Western United States
On Apr. 16, 1993, the U.S. Centers for Disease Control (CDC) reported that from November 15, 1992, through…
Biotechnology | Chemistry | Disease | FDA | Therapeutics
The Earl Davie/ZymoGenetics Endowed Chair of Biochemistry at the University of Washington was established
On Apr. 14, 1993, the Earl Davie/ZymoGenetics Endowed Chair of Biochemistry at the University of Washington was established…
James Watson resigned as head of Human Genome Project over NIH efforts to patent gene fragments
In April 1993, James Watson resigned as head of National Human Genome Research Institute (NCHGR) following allegations that…
Biotechnology | FDA | Oncology | Therapeutics
The FDA approved Amgen’s Epogen/Procrit for the treatment of anemia
On Apr. 1, 1993, the FDA approved Amgen’s Epogen/Procrit for the treatment of anemia due to the effects…
The FDA approved use of a new haemophilus b conjugate vaccine for infants and children
On Mar. 30, 1993, the U.S. Food and Drug Administration (FDA) approved a new Haemophilus b conjugate vaccine,…
The Pappajohn Clinical Cancer Center opens for service
In 1993, the John and Mary Pappajohn Clinical Cancer Center opened for service after receiving a generous $25…
Biotechnology | Medicine | Neurology | NIH
Start of neurosurgical therapies for Parkinson’s disease began
In 1993, Patricia Limousin and Irene Martinez-Torres demonstrated the role of the subthalamic nucleus (STN) in the pathophysiology…